Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 273

1.

Natural enemy or friend? Pneumonia in the very elderly critically ill patient.

Niederman MS.

Eur Respir Rev. 2020 Feb 19;29(155). pii: 200031. doi: 10.1183/16000617.0031-2020. Print 2020 Mar 31. No abstract available.

PMID:
32075859
2.

Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial.

Niederman MS, Alder J, Bassetti M, Boateng F, Cao B, Corkery K, Dhand R, Kaye KS, Lawatscheck R, McLeroth P, Nicolau DP, Wang C, Wood GC, Wunderink RG, Chastre J.

Lancet Infect Dis. 2019 Dec 19. pii: S1473-3099(19)30574-2. doi: 10.1016/S1473-3099(19)30574-2. [Epub ahead of print]

PMID:
31866328
3.

Survival benefit associated with clarithromycin in severe community-acquired pneumonia: A matched comparator study.

Kyriazopoulou E, Sinapidis D, Halvatzis S, Velissaris D, Alexiou N, Kosmas V, Adami ME, Kyprianou M, Kyprianou A, Stefos A, Lada M, Koutoukas P, Pavlaki M, Kyriakoudi A, Makina A, Gogos C, Niederman MS, Giamarellos-Bourboulis EJ.

Int J Antimicrob Agents. 2020 Jan;55(1):105836. doi: 10.1016/j.ijantimicag.2019.10.017. Epub 2019 Nov 5.

PMID:
31704213
4.

Effect of Corticosteroids on C-Reactive Protein in Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: The Effect of Lymphopenia.

Torres A, Ceccato A, Ferrer M, Gabarrus A, Sibila O, Cilloniz C, Mendez R, Menendez R, Bermejo-Martin J, Niederman MS.

J Clin Med. 2019 Sep 13;8(9). pii: E1461. doi: 10.3390/jcm8091461.

5.

Telavancin in Hospital-Acquired and Ventilator-Associated Pneumonia (HAP/VAP) Caused by Staphylococcus aureus: Post Hoc Analysis of 2 Randomized, Controlled Trials.

Niederman MS, Lee PC, Barriere SL, Barnes CN, Castaneda-Ruiz B.

Infect Dis Ther. 2019 Sep;8(3):445-452. doi: 10.1007/s40121-019-0255-0. Epub 2019 Aug 1.

6.

Clinical Impact of Antimicrobial Resistance: Using New Tools to Answer Old Questions.

Niederman MS.

Chest. 2019 Jun;155(6):1088-1089. doi: 10.1016/j.chest.2019.02.324. No abstract available.

PMID:
31174629
7.

Adjunctive Nebulized Antibiotics: What Is Their Place in ICU Infections?

Niederman MS.

Front Med (Lausanne). 2019 May 8;6:99. doi: 10.3389/fmed.2019.00099. eCollection 2019. Review.

8.

Aspiration Pneumonia. Reply.

Mandell LA, Niederman MS.

N Engl J Med. 2019 May 23;380(21):e40. doi: 10.1056/NEJMc1903636. No abstract available.

PMID:
31116944
9.

Update in Lung Infections and Tuberculosis 2018.

Niederman MS, Nair GB, Matt U, Herold S, Pennington K, Crothers K, Cummings M, Schluger NW.

Am J Respir Crit Care Med. 2019 Aug 15;200(4):414-422. doi: 10.1164/rccm.201903-0606UP. No abstract available.

PMID:
31042415
10.

Editorial: Toward improving the diagnosis, treatment and prevention of community acquired and nosocomial respiratory tract infections.

Niederman MS, Zumla A.

Curr Opin Pulm Med. 2019 May;25(3):217-219. doi: 10.1097/MCP.0000000000000577. No abstract available.

PMID:
30920457
11.

Aspiration Pneumonia.

Mandell LA, Niederman MS.

N Engl J Med. 2019 Feb 14;380(7):651-663. doi: 10.1056/NEJMra1714562. Review. No abstract available.

PMID:
30763196
12.

Effect of Combined β-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired Pneumonia.

Ceccato A, Cilloniz C, Martin-Loeches I, Ranzani OT, Gabarrus A, Bueno L, Garcia-Vidal C, Ferrer M, Niederman MS, Torres A.

Chest. 2019 Apr;155(4):795-804. doi: 10.1016/j.chest.2018.11.006. Epub 2018 Nov 22.

13.

Respiratory Infections: An Ongoing Challenge with a Promising Future.

Niederman MS.

Clin Chest Med. 2018 Dec;39(4):xv-xvi. doi: 10.1016/j.ccm.2018.09.001. No abstract available.

PMID:
30390756
14.

Beat around the bush for VA-LRTI.

Martin-Loeches I, Depuydt P, Niederman MS.

Intensive Care Med. 2018 Nov;44(11):1961-1963. doi: 10.1007/s00134-018-5281-y. Epub 2018 Oct 21. No abstract available.

PMID:
30343316
15.

Decreased relative risk of pneumococcal pneumonia during the last decade, a nested case-control study.

Luna CM, Pulido L, Niederman MS, Casey A, Burgos D, Leiva Agüero SD, Grosso A, Membriani E, Entrocassi AC, Rodríquez Fermepin M, Vay CA, Garcia S, Famiglietti A.

Pneumonia (Nathan). 2018 Sep 25;10:9. doi: 10.1186/s41479-018-0053-6. eCollection 2018.

16.

A Therapeutic Strategy for All Pneumonia Patients: A 3-Year Prospective Multicenter Cohort Study Using Risk Factors for Multidrug-resistant Pathogens to Select Initial Empiric Therapy.

Maruyama T, Fujisawa T, Ishida T, Ito A, Oyamada Y, Fujimoto K, Yoshida M, Maeda H, Miyashita N, Nagai H, Imamura Y, Shime N, Suzuki S, Amishima M, Higa F, Kobayashi H, Suga S, Tsutsui K, Kohno S, Brito V, Niederman MS.

Clin Infect Dis. 2019 Mar 19;68(7):1080-1088. doi: 10.1093/cid/ciy631.

PMID:
30084884
17.

Antibiotic treatment of hospital-acquired pneumonia: is it different from ventilator-associated pneumonia?

Niederman MS.

Curr Opin Crit Care. 2018 Oct;24(5):353-360. doi: 10.1097/MCC.0000000000000531. Review.

PMID:
30028739
18.

Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia.

Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, Kollef M, Li Bassi G, Luna CM, Martin-Loeches I, Paiva JA, Read RC, Rigau D, François Timsit J, Welte T, Wunderink R.

ERJ Open Res. 2018 Jun 26;4(2). pii: 00028-2018. doi: 10.1183/23120541.00028-2018. eCollection 2018 Apr.

19.

Pneumonia Complicating COPD: Are Corticosteroids a Help or a Hindrance?

Niederman MS.

Chronic Obstr Pulm Dis. 2018 Jan 18;5(1):1-4. doi: 10.15326/jcopdf.5.1.2018.0162. No abstract available.

20.

Future Research Directions in Pneumonia. NHLBI Working Group Report.

Dela Cruz CS, Wunderink RG, Christiani DC, Cormier SA, Crothers K, Doerschuk CM, Evans SE, Goldstein DR, Khatri P, Kobzik L, Kolls JK, Levy BD, Metersky ML, Niederman MS, Nusrat R, Orihuela CJ, Peyrani P, Prince AS, Ramírez JA, Ridge KM, Sethi S, Suratt BT, Sznajder JI, Tsalik EL, Walkey AJ, Yende S, Aggarwal NR, Caler EV, Mizgerd JP.

Am J Respir Crit Care Med. 2018 Jul 15;198(2):256-263. doi: 10.1164/rccm.201801-0139WS.

21.

Imaging for the Management of Community-Acquired Pneumonia: What to Do if the Chest Radiograph Is Clear.

Niederman MS.

Chest. 2018 Mar;153(3):583-585. doi: 10.1016/j.chest.2017.09.045. No abstract available.

PMID:
29519296
22.

Adjuvant therapies in critical care: steroids in community-acquired pneumonia.

Torres A, Ferrer M, Niederman MS.

Intensive Care Med. 2018 Apr;44(4):478-481. doi: 10.1007/s00134-017-4967-x. Epub 2017 Oct 25. No abstract available.

PMID:
29071427
23.

Multi-drug resistant organism infections in a medical ICU: Association to clinical features and impact upon outcome.

Magira EE, Islam S, Niederman MS.

Med Intensiva. 2018 May;42(4):225-234. doi: 10.1016/j.medin.2017.07.006. Epub 2017 Oct 13. English, Spanish.

24.

Evaluation of the 2016 Infectious Diseases Society of America/American Thoracic Society Guideline Criteria for Risk of Multidrug-Resistant Pathogens in Patients with Hospital-acquired and Ventilator-associated Pneumonia in the ICU.

Ekren PK, Ranzani OT, Ceccato A, Li Bassi G, Muñoz Conejero E, Ferrer M, Niederman MS, Torres A.

Am J Respir Crit Care Med. 2018 Mar 15;197(6):826-830. doi: 10.1164/rccm.201708-1717LE. No abstract available.

PMID:
28902529
26.

Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial.

Ceccato A, Cilloniz C, Ranzani OT, Menendez R, Agusti C, Gabarrus A, Ferrer M, Sibila O, Niederman MS, Torres A.

PLoS One. 2017 Jun 15;12(6):e0178022. doi: 10.1371/journal.pone.0178022. eCollection 2017.

27.

Using Ventilator-Associated Pneumonia Rates as a Health Care Quality Indicator: A Contentious Concept.

Nair GB, Niederman MS.

Semin Respir Crit Care Med. 2017 Jun;38(3):237-244. doi: 10.1055/s-0037-1602580. Epub 2017 Jun 4. Review.

PMID:
28578548
28.

The research agenda in VAP/HAP: next steps.

Niederman MS, Martin-Loeches I, Torres A.

Intensive Care Med. 2017 Sep;43(9):1389-1391. doi: 10.1007/s00134-017-4695-2. Epub 2017 Feb 14. No abstract available.

PMID:
28197677
29.

Antibiotic therapy prior to hospital admission is associated with reduced septic shock and need for mechanical ventilation in patients with community-acquired pneumonia.

Amaro R, Sellarés J, Polverino E, Cillóniz C, Ferrer M, Fernández-Barat L, Mensa J, Niederman MS, Torres A.

J Infect. 2017 May;74(5):442-449. doi: 10.1016/j.jinf.2017.01.009. Epub 2017 Jan 24.

PMID:
28130142
30.

Invasive Disease vs Urinary Antigen-Confirmed Pneumococcal Community-Acquired Pneumonia.

Ceccato A, Torres A, Cilloniz C, Amaro R, Gabarrus A, Polverino E, Prina E, Garcia-Vidal C, Muñoz-Conejero E, Mendez C, Cifuentes I, Puig de la Bella Casa J, Menendez R, Niederman MS.

Chest. 2017 Jun;151(6):1311-1319. doi: 10.1016/j.chest.2017.01.005. Epub 2017 Jan 16.

31.

Principles of Antibiotic Management of Community-Acquired Pneumonia.

Bender MT, Niederman MS.

Semin Respir Crit Care Med. 2016 Dec;37(6):905-912. Epub 2016 Dec 13. Review.

PMID:
27960214
32.

Serum procalcitonin and the admission decision in CAP.

Niederman MS.

Lancet Respir Med. 2016 Dec;4(12):956. doi: 10.1016/S2213-2600(16)30383-6. Epub 2016 Nov 22. No abstract available.

PMID:
27890506
33.

The Impact of Age and Comorbidities on the Mortality of Patients of Different Age Groups Admitted with Community-acquired Pneumonia.

Luna CM, Palma I, Niederman MS, Membriani E, Giovini V, Wiemken TL, Peyrani P, Ramirez J.

Ann Am Thorac Soc. 2016 Sep;13(9):1519-26. doi: 10.1513/AnnalsATS.201512-848OC.

PMID:
27398827
34.

Lessons learned from 2 decades of CAP therapy data: ways to improve patient management.

Bender MT, Niederman MS.

J Thorac Dis. 2016 Jun;8(6):E455-9. doi: 10.21037/jtd.2016.04.36. No abstract available.

35.

Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.

Cillóniz C, Gabarrús A, Ferrer M, Puig de la Bellacasa J, Rinaudo M, Mensa J, Niederman MS, Torres A.

Chest. 2016 Aug;150(2):415-25. doi: 10.1016/j.chest.2016.03.042. Epub 2016 Apr 7.

PMID:
27060725
36.

Understanding community-acquired respiratory tract infections: new concepts of disease pathogenesis and new management strategies.

Niederman MS, Zumla A.

Curr Opin Pulm Med. 2016 May;22(3):193-5. doi: 10.1097/MCP.0000000000000274. No abstract available.

PMID:
27035243
37.

What is Legionnaires' Disease?

Marion CR, Dela Cruz CS, Niederman MS.

Am J Respir Crit Care Med. 2016 Feb 15;193(4):P5-6. doi: 10.1164/rccm.1934P5. No abstract available.

PMID:
26871677
38.

Improving outcomes in community-acquired pneumonia.

Bender MT, Niederman MS.

Curr Opin Pulm Med. 2016 May;22(3):235-42. doi: 10.1097/MCP.0000000000000257. Review.

PMID:
26859379
39.

The road forward in the management of Acinetobacter infections in the ICU.

Niederman MS, Kollef MH.

Intensive Care Med. 2015 Dec;41(12):2207-9. No abstract available.

PMID:
26499480
40.

Why is Acinetobacter baumannii a problem for critically ill patients?

Kollef MH, Niederman MS.

Intensive Care Med. 2015 Dec;41(12):2170-2. No abstract available.

PMID:
26474995
41.

In the Clinic: Community-Acquired Pneumonia.

Niederman MS.

Ann Intern Med. 2015 Oct 6;163(7):ITC1-17. doi: 10.7326/AITC201510060. Review. No abstract available.

PMID:
26436631
42.

Real life management of community-acquired Pneumonia in adults in the Gulf region and comparison with practice guidelines: a prospective study.

Mahboub B, Al Zaabi A, Al Ali OM, Ahmed R, Niederman MS, El-Bishbishi R.

BMC Pulm Med. 2015 Sep 30;15:112. doi: 10.1186/s12890-015-0108-x.

43.

Outcomes and Prognostic Features of Patients With Influenza Requiring Hospitalization and Receiving Early Antiviral Therapy: A Prospective Multicenter Cohort Study.

Maruyama T, Fujisawa T, Suga S, Nakamura H, Nagao M, Taniguchi K, Tsutsui K, Ihara T, Niederman MS.

Chest. 2016 Feb;149(2):526-534. doi: 10.1378/chest.14-2768. Epub 2016 Jan 12.

PMID:
26203671
44.

Predictors of Clinical Success in the Treatment of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Nosocomial Pneumonia (NP).

Shorr AF, Puzniak LA, Biswas P, Niederman MS.

PLoS One. 2015 Jul 21;10(7):e0131932. doi: 10.1371/journal.pone.0131932. eCollection 2015.

45.

Macrolide-Resistant Pneumococcus in Community-acquired Pneumonia. Is There Still a Role for Macrolide Therapy?

Niederman MS.

Am J Respir Crit Care Med. 2015 Jun 1;191(11):1216-7. doi: 10.1164/rccm.201504-0701ED. No abstract available.

PMID:
26029831
46.

Ventilator-associated pneumonia prevention: response to Silvestri et al.

Nair GB, Niederman MS.

Intensive Care Med. 2015 May;41(5):957. doi: 10.1007/s00134-015-3756-7. Epub 2015 Mar 31. No abstract available.

PMID:
25821904
47.

Respiratory tract infections in community and healthcare settings: epidemiological, diagnostic and management challenges.

Zumla A, Niederman MS.

Curr Opin Pulm Med. 2015 May;21(3):209-11. doi: 10.1097/MCP.0000000000000163. No abstract available.

PMID:
25784249
48.

Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial.

Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J, Gabarrús A, Sellarés J, Restrepo MI, Anzueto A, Niederman MS, Agustí C.

JAMA. 2015 Feb 17;313(7):677-86. doi: 10.1001/jama.2015.88.

49.

Year in review 2013: Critical Care--respiratory infections.

Nair GB, Niederman MS.

Crit Care. 2014 Oct 29;18(5):572. doi: 10.1186/s13054-014-0572-3. Review.

50.

Managing ventilator complications in a "VACuum" of data.

Niederman MS, Nair GB.

Chest. 2015 Jan;147(1):5-6. doi: 10.1378/chest.14-1496. No abstract available.

PMID:
25560851

Supplemental Content

Loading ...
Support Center